Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

RAC1 activation drives pathologic interactions between the epidermis and immune cells.

Winge MC, Ohyama B, Dey CN, Boxer LM, Li W, Ehsani-Chimeh N, Truong AK, Wu D, Armstrong AW, Makino T, Davidson M, Starcevic D, Kislat A, Nguyen NT, Hashimoto T, Homey B, Khavari PA, Bradley M, Waterman EA, Marinkovich MP.

J Clin Invest. 2016 Jul 1;126(7):2661-77. doi: 10.1172/JCI85738. Epub 2016 Jun 13.

2.

The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.

Xiang H, Noonan EJ, Wang J, Duan H, Ma L, Michie S, Boxer LM.

Leukemia. 2011 Sep;25(9):1484-93. doi: 10.1038/leu.2011.115. Epub 2011 May 24.

3.

Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.

Duan H, Xiang H, Ma L, Boxer LM.

Oncogene. 2008 Dec 4;27(53):6720-8. doi: 10.1038/onc.2008.286. Epub 2008 Aug 11.

4.

Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability.

Dhakshinamoorthy S, Sridharan SR, Li L, Ng PY, Boxer LM, Porter AG.

Nucleic Acids Res. 2007;35(16):5439-51. Epub 2007 Aug 15.

5.

Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.

Hu HM, Kanda K, Zhang L, Boxer LM.

Leukemia. 2007 Apr;21(4):747-53. Epub 2007 Feb 8.

PMID:
17287852
6.

Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines.

Gao J, Liu YG, Zhou Y, Boxer LM, Woolley FR, Zingaro RA.

Chembiochem. 2007 Feb 12;8(3):332-40.

PMID:
17203500
7.

The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.

Duan H, Heckman CA, Boxer LM.

Oncogene. 2007 Apr 19;26(18):2635-41. Epub 2006 Oct 16.

PMID:
17043638
8.
9.

Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.

Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM, Liang Q.

FASEB J. 2006 Apr;20(6):800-2. Epub 2006 Feb 9.

PMID:
16469847
10.

CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.

Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD.

Mol Cancer Res. 2005 Oct;3(10):585-96.

11.

Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.

Heckman CA, Duan H, Garcia PB, Boxer LM.

Oncogene. 2006 Feb 9;25(6):888-98.

PMID:
16186795
12.
13.
14.

A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.

Fine BM, Kaspers GJ, Ho M, Loonen AH, Boxer LM.

Cancer Res. 2005 Jan 1;65(1):291-9.

15.
16.

Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.

Heckman CA, Cao T, Somsouk L, Duan H, Mehew JW, Zhang CY, Boxer LM.

Cancer Res. 2003 Oct 15;63(20):6666-73.

17.

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.

Fine BM, Stanulla M, Schrappe M, Ho M, Viehmann S, Harbott J, Boxer LM.

Blood. 2004 Feb 1;103(3):1043-9. Epub 2003 Oct 2.

18.

Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.

Heckman CA, Wheeler MA, Boxer LM.

Oncogene. 2003 Sep 11;22(39):7891-9.

PMID:
12970736
19.

Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells.

Jambal P, Masterson S, Nesterova A, Bouchard R, Bergman B, Hutton JC, Boxer LM, Reusch JE, Pugazhenthi S.

J Biol Chem. 2003 Jun 20;278(25):23055-65. Epub 2003 Apr 5.

20.

Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons.

Pugazhenthi S, Nesterova A, Jambal P, Audesirk G, Kern M, Cabell L, Eves E, Rosner MR, Boxer LM, Reusch JE.

J Neurochem. 2003 Mar;84(5):982-96.

22.

Allele-specific analysis of transcription factors binding to promoter regions.

Heckman CA, Boxer LM.

Methods. 2002 Jan;26(1):19-26.

PMID:
12054901
23.

NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells.

Heckman CA, Mehew JW, Boxer LM.

Oncogene. 2002 May 30;21(24):3898-908.

24.
26.

Translocations involving c-myc and c-myc function.

Boxer LM, Dang CV.

Oncogene. 2001 Sep 10;20(40):5595-610. Review.

27.

The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells.

Freeland K, Boxer LM, Latchman DS.

Brain Res Mol Brain Res. 2001 Aug 15;92(1-2):98-106.

PMID:
11483246
28.

Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma.

Arcinas M, Heckman CA, Mehew JW, Boxer LM.

Cancer Res. 2001 Jul 1;61(13):5202-6.

29.

Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl.

Sinha S, Jancarik J, Roginskaya V, Rothermund K, Boxer LM, Corey SJ.

Exp Hematol. 2001 Jun;29(6):746-55.

PMID:
11378270
30.

Negative regulation of bcl-2 expression by p53 in hematopoietic cells.

Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM.

Oncogene. 2001 Jan 11;20(2):240-51.

31.

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.

Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JE.

J Biol Chem. 2000 Apr 14;275(15):10761-6.

32.
33.

NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.

Kanda K, Hu HM, Zhang L, Grandchamps J, Boxer LM.

J Biol Chem. 2000 Oct 13;275(41):32338-46.

34.

A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.

Heckman CA, Mehew JW, Ying GG, Introna M, Golay J, Boxer LM.

J Biol Chem. 2000 Mar 3;275(9):6499-508.

35.

The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M.

Liu J, Li C, Ahlborn TE, Spence MJ, Meng L, Boxer LM.

Cell Growth Differ. 1999 Oct;10(10):677-83.

36.

Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein.

Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM, Reusch JE.

J Biol Chem. 1999 Sep 24;274(39):27529-35.

37.

A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells.

Chalaux E, López-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura F.

FEBS Lett. 1999 Sep 3;457(3):478-82.

38.

p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor.

Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS.

J Biol Chem. 1999 May 21;274(21):15237-44.

39.

Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade.

Liu YZ, Boxer LM, Latchman DS.

Nucleic Acids Res. 1999 May 15;27(10):2086-90.

41.

Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor.

Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS.

J Biol Chem. 1998 Jul 3;273(27):16715-22.

42.

The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas.

Heckman C, Mochon E, Arcinas M, Boxer LM.

J Biol Chem. 1997 Aug 1;272(31):19609-14.

43.

A woman who had a stroke, then a myocardial infarction.

Ciesielski-Carlucci C, Lee BK, Boxer LM, Leung LL.

Lancet. 1997 Apr 26;349(9060):1218. No abstract available. Erratum in: Lancet 1997 Aug 2;350(9074):372.

PMID:
9130944
44.

Baricity, needle direction, and intrathecal sufentanil labor analgesia.

Ferouz F, Norris MC, Arkoosh VA, Leighton BL, Boxer LM, Corba RJ.

Anesthesiology. 1997 Mar;86(3):592-8.

PMID:
9066324
45.

Identification of the major positive regulators of c-myb expression in hematopoietic cells of different lineages.

Sullivan J, Feeley B, Guerra J, Boxer LM.

J Biol Chem. 1997 Jan 17;272(3):1943-9.

46.
47.

CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas.

Ji L, Mochon E, Arcinas M, Boxer LM.

J Biol Chem. 1996 Sep 13;271(37):22687-91.

48.

Identification of an inducible regulator of c-myb expression during T-cell activation.

Phan SC, Feeley B, Withers D, Boxer LM.

Mol Cell Biol. 1996 May;16(5):2387-93.

49.

Repression of the c-myb gene by WT1 protein in T and B cell lines.

McCann S, Sullivan J, Guerra J, Arcinas M, Boxer LM.

J Biol Chem. 1995 Oct 6;270(40):23785-9.

50.

Myb binding sites mediate negative regulation of c-myb expression in T-cell lines.

Guerra J, Withers DA, Boxer LM.

Blood. 1995 Sep 1;86(5):1873-80.

Supplemental Content

Loading ...
Support Center